
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd.(ENLV)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
enlv · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$15.00
Consensus
$15.00
+2000.3% upside
Low
$15.00
Median: $15 · Last Close: $0.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.73 | ↑ 2.45% |
1-day model range: $0.72–$0.75. Peak: $0.75 (+2.45%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ENLV · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-24 | D. Boral Capital | Downgrade ↓ | Buy→Hold |
| 2025-10-29 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-09-26 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-09-12 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-09-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-22 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-18 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-07-29 | D. Boral Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Enlivex Therapeutics Ltd. (ENLV) stock. Of the recent 31 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover ENLV.
分析师推荐趋势
ENLV analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-0.65
EPS Next Year
$-0.40
↓ 39.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast ENLV EPS of $-0.65 for the current fiscal year, based on estimates from 1 analysts. The ENLV revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ENLV 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ENLV 的共识目标价为 $15.00(+2000.3% 上行空间),分析师共识为 Buy。
ENLV 的短期预测(明日)为 $0.73(+2.45%)。 ENLV 对 2030 年的预测区间为 $0–$0。
Enlivex Therapeutics Ltd. 在 NASDAQ 上市,代码 ENLV。ENLV 在 2027 年的整体展望偏积极,在覆盖分析师中约 75% 对应 Buy 共识。
常见问题
ENLV 预测 · 8 个问题根据 4 位华尔街分析师,ENLV 的 12 个月平均目标价为 $15.00,最高 $15.00、最低 $15.00。若有图表,中位目标价可在上方查看。相对当前价 $0.71,隐含约 +2000.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.